e-learning
resources
Stockholm 2007
Monday 17.09.2007
Pulmonary biomarkers in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical implications
P. J. Barnes (London, United Kingdom)
Source:
Annual Congress 2007 - Pulmonary biomarkers in COPD
Session:
Pulmonary biomarkers in COPD
Session type:
Symposium
Number:
1531
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. J. Barnes (London, United Kingdom). Clinical implications. Annual Congress 2007 - Pulmonary biomarkers in COPD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018
Therapeutic implications
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009
Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008
Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
Source: Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020
Year: 2020
Clinical implications – potential future developments in EBC research
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007
Variation among spirometry interpretation algorithms: Clinical implications
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010
Physiologic rationale and clinical pitfalls
Source: Virtual Congress 2021 – High flow nasal cannula in adults with acute respiratory failure
Year: 2021
Therapeutic and management implications
Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited
Year: 2010
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
Clinical approach
Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea
Year: 2021
Therapeutic implications
Source: Annual Congress 2011 - Accelerated lung ageing in COPD
Year: 2011
Clinical classification of pulmonary hypertension(PH) and implications for survival
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Implications of the exposome and its applicability in clinical and epidemiological studies
Source: International Congress 2016 – Genetics, epigenetics and the exposome
Year: 2016
Ethical aspects of pandemics – clinical implications
Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage
Year: 2017
Biomarkers for clinical management
Source: International Congress 2017 – PG12 Life-threatening pulmonary infections
Year: 2017
Clinical phenotyping: role in treatment decisions in sarcoidosis
Source: Eur Respir Rev, 29 (155) 190145; 10.1183/16000617.0145-2019
Year: 2020
Clinical implications of host-bacteria-virus interactions in lung transplantation
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept